Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk - Never Judge a Book by Its Cover

Circ J. 2023 May 25;87(6):764-766. doi: 10.1253/circj.CJ-23-0170. Epub 2023 Apr 7.

Author

Raisuke Iijima¹

Affiliation

¹ Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University.

PMID: 37032075
DOI: 10.1253/circj.CJ-23-0170

No abstract available

MeSH terms

Acute Coronary Syndrome* / drug therapy
Clopidogrel
Cytochrome P-450 CYP2C19 / genetics
Genotype
Heart
Hemorrhage / chemically induced
Humans
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors / adverse effects
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Cytochrome P-450 CYP2C19